Weight, patient symptoms and device-based activity for decompensated versus non-decompensated HF patients

被引：0
|
作者：
Verwey, HF
Molhoek, SG
Sweeney, R
Troiani, J
Vanstraelen, K
van Wemelen, R
Schubert, B
Schalij, MJ
机构：
[1] Leiden Univ, Med Ctr, NL-2300 RA Leiden, Netherlands
[2] Guidant Corp, St Paul, MN USA
[3] Guidant Clin Res EMEAC, Diegem, Belgium
来源：
JOURNAL OF CARDIAC FAILURE | 2005年 / 11卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
365
引用
收藏
页码：S187 / S187
页数：1
相关论文
共 50 条
  • [41] Patient characteristics and cancer prevalence in the Danish cancer patient pathway for patients with serious non-specific symptoms and signs of cancer-A nationwide, population-based cohort study
    Moseholm, E.
    Lindhardt, B. O.
    CANCER EPIDEMIOLOGY, 2017, 50 : 166 - 172
  • [42] Impact of rehabilitation unit-based physical activity therapy versus symptomatic supportive treatment on older patients with advanced cancer: a non-randomized controlled study
    Lu, Xiaoqiong
    Wei, Shubao
    Liang, Benzi
    Huang, Cheng
    Meng, Weiwei
    Zhang, Xiaojing
    Chen, Xiuqiong
    SUPPORTIVE CARE IN CANCER, 2024, 32 (08)
  • [43] Prediction Of Week 52 Treatment Response Based On A Week 12 Assessment In Rheumatoid Arthritis Patients Receiving Certolizumab Pegol: Comparison Of A Patient-Reported Instrument Versus Physician-Based Disease Activity Assessment
    Curtis, Jeffrey R.
    Koetse, Willem
    Tambiah, Jeymi
    Ionescu, Lucian
    Yazici, Yusuf
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S186 - S187
  • [44] Patient-Reported Neuropathy and Taxane-Associated Symptoms in a Phase 3 Trial of nab-Paclitaxel Plus Carboplatin versus Solvent-Based Paclitaxel Plus Carboplatin for Advanced Non-Small-Cell Lung Cancer
    Hirsh, Vera
    Okamoto, Isamu
    Hon, Jeremy K.
    Page, Ray D.
    Orsini, James
    Sakai, Hiroshi
    Zhang, Hui
    Renschler, Markus F.
    Socinski, Mark A.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (01) : 83 - 90
  • [45] Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation
    Patel, Siddharth M.
    Braunwald, Eugene
    Steffel, Jan
    Boriani, Giuseppe
    Palazzolo, Michael G.
    Antman, Elliott M.
    Bohula, Erin A.
    Carnicelli, Anthony P.
    Connolly, Stuart J.
    Eikelboom, John W.
    Gencer, Baris
    Granger, Christopher B.
    Morrow, David A.
    Patel, Manesh R.
    Wallentin, Lars
    Ruff, Christian T.
    Giugliano, Robert P.
    CIRCULATION, 2024, 149 (12) : 932 - 943
  • [46] A phase IV, randomized, multicenter, open-label trial comparing efficacy and systemic exposure for a standard weight-based dose versus a fixed dose of plerixafor in combination with G-CSF in patients with Non-Hodgkin’s lymphoma weighing ≤70 kg
    John Kuruvilla
    Cheng-Hwai Tzeng
    Seok-Goo Cho
    Seok Jin Kim
    Jih-Luh Tang
    Yaming Su
    Jingyang Wu
    Rita Vargo
    Peter Cheverton
    Bone Marrow Transplantation, 2019, 54 : 258 - 264
  • [47] A phase IV, randomized, multicenter, open-label trial comparing efficacy and systemic exposure for a standard weight-based dose versus a fixed dose of plerixafor in combination with G-CSF in patients with Non-Hodgkin's lymphoma weighing ≤70 kg
    Kuruvilla, John
    Tzeng, Cheng-Hwai
    Cho, Seok-Goo
    Kim, Seok Jin
    Tang, Jih-Luh
    Su, Yaming
    Wu, Jingyang
    Vargo, Rita
    Cheverton, Peter
    BONE MARROW TRANSPLANTATION, 2019, 54 (02) : 258 - 264
  • [48] EAST-LC: Randomized controlled phase III trial of S-1 versus docetaxel (DOC) in patients with non-small cell lung cancer (NSCLC) who had received a platinum-based treatment: Results from patient-reported outcomes (PROs)
    Soo, R.
    Mok, T. S. K.
    Shi, Y-K.
    Zhang, L.
    Lu, S.
    Yang, J. C-H.
    Nakagawa, K.
    Yamamoto, N.
    Nokihara, H.
    Sugawara, S.
    Nishio, M.
    Takahashi, T.
    Goto, K.
    Chang, J.
    Maemondo, M.
    Ichinose, Y.
    Cheng, Y.
    Lim, W.
    Morita, S.
    Tamura, T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [49] PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial (vol 24, 823, 2024)
    Nankivell, Paul
    Gaunt, Piers
    Gaunt, Claire
    Sissons, Julia
    Liaskou, Evaggelia
    Jefferson, Yolande
    Fulton-Lieuw, Tessa
    Mittal, Saloni
    Mehanna, Hisham
    BMC CANCER, 2024, 24 (01)
  • [50] Postoperative outcomes among Northern versus Southern Ontario patients undergoing common intermediate- to high-risk elective surgeries: a population-based cohort studyNorthern vs Southern Ontario postoperative outcomesComparaison des issues postopératoires de la patientèleM. Chen et al.Comparaison des issues postopératoires de la patientèle bénéficiant de chirurgies non urgentes courantes à risque intermédiaire à élevé entre le Nord et le Sud de l’Ontario : une étude de cohorte basée sur la population
    Max Chen
    Kaitlin Duncan
    Robert Talarico
    Sarah McIsaac
    Daniel I. McIsaac
    Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2024, 71 (12): : 1705 - 1715
12345